LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 7.77 | 84.90 | 805 | 411 | 1.9575 | 1.6865 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 9.47 | 84.90 | 909 | 447 | 2.0316 | 1.6879 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 9.47 | 84.90 | 889 | 447 | 1.9869 | 1.6631 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 11.18 | 84.90 | 958 | 492 | 1.9457 | 1.6003 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 11.18 | 84.90 | 11 | 492 | 0.0223 | -0.5533 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 11.18 | 84.90 | 963 | 492 | 1.9559 | 1.6057 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 12.88 | 84.90 | 3 | 531 | 0.0056 | -0.7174 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 12.88 | 84.90 | 1076 | 531 | 2.0264 | 1.6121 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 12.88 | 84.90 | 234 | 531 | 0.4407 | 0.4672 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 12.88 | 84.90 | 1071 | 531 | 2.0169 | 1.6075 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 14.58 | 84.90 | 1 | 663 | 0.0015 | -0.7763 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 14.58 | 84.90 | 1133 | 663 | 1.7079 | 1.3955 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 14.58 | 84.90 | 577 | 663 | 0.8698 | 0.9081 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 14.58 | 84.90 | 1137 | 663 | 1.7139 | 1.3984 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 16.29 | 84.90 | 5 | 766 | 0.0065 | -0.5901 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 16.29 | 84.90 | 1218 | 766 | 1.5883 | 1.3137 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 16.29 | 84.90 | 767 | 766 | 1.0002 | 1.0001 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 16.29 | 84.90 | 1192 | 766 | 1.5544 | 1.2981 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 17.99 | 84.90 | 7 | 898 | 0.0078 | -0.5195 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 17.99 | 84.90 | 1341 | 898 | 1.4917 | 1.2493 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 17.99 | 84.90 | 925 | 898 | 1.0289 | 1.0168 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 17.99 | 84.90 | 1296 | 898 | 1.4416 | 1.2268 | MN20160318_Q02 | N08 |